C-MER Medical Holdings Limited (HKG:3309)
Hong Kong · Delayed Price · Currency is HKD 1.840
-0.020 (-1.08%)
Aug 12, 2025, 3:59 PM HKT
C-MER Medical Holdings Market Cap
C-MER Medical Holdings has a market cap or net worth of 2.29 billion as of August 12, 2025. Its market cap has decreased by -31.43% in one year.
Market Cap
2.29B
Enterprise Value
2.40B
Revenue
1.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
1.84
Market Cap Chart
Since January 15, 2018, C-MER Medical Holdings's market cap has decreased from 5.11B to 2.29B, a decrease of -55.10%. That is a compound annual growth rate of -10.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 2.32B | -5.50% |
| Dec 31, 2024 | 2.45B | -42.85% |
| Dec 29, 2023 | 4.29B | -30.80% |
| Dec 30, 2022 | 6.21B | -21.70% |
| Dec 31, 2021 | 7.93B | 20.36% |
| Dec 31, 2020 | 6.59B | 25.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 248.91B |
| Hansoh Pharmaceutical Group Company | 210.36B |
| JD Health International | 168.97B |
| Innovent Biologics | 156.29B |
| Akeso | 143.97B |
| Sino Biopharmaceutical | 131.63B |
| WuXi Biologics | 119.51B |
| CSPC Pharmaceutical Group | 117.30B |